申请人:Hokuriku Pharmaceutical Co.,Ltd
公开号:EP0273375A2
公开(公告)日:1988-07-06
The use of propiophenone derivatives of the general Formula (I)
is described,
wherein R₁, R₂ and R₃, which may be the same or different, each independently represents hydrogen, halogen, lower alkyl- or halogeno-lower-alkyl group having a straight or branched carbon chain, a lower-alkoxy group or a cycloalkyl group having 3-8 carbon atoms, two of which R₁, R₂, and R₃ groups may combine to form methylenedioxy or ethyleneoxy, R₄ represents hydrogen or a lower-alkyl group having a straight or branched carbon chain, and A represents pyrrolidinyl-, piperidinyl-, morpholinyl-, or azepinyl or a pharmaceutically acceptable acid addition salt thereof, for the manufacture of a medicament for treatment of frequency urination.
通式(I)的苯丙酮衍生物的用途
的苯丙酮衍生物的用途、
其中 R₁、R₂ 和 R₃ 可以相同或不同,各自独立地代表氢、卤素、具有直链或支链碳链的低级烷基或卤代低级烷基、低级烷氧基或具有 3-8 个碳原子的环烷基,其中两个 R₁、R₂ 和 R₃ 基团可结合形成亚甲基二氧基或亚乙氧基、R₄ 代表氢或具有直链或支链碳链的低级烷基,A 代表吡咯烷基、哌啶基、吗啉基或氮杂环庚基或其药学上可接受的酸加成盐,用于制造治疗尿频的药物。